▶ 調査レポート

塞栓粒子の世界市場レポート2020

• 英文タイトル:Global Embolization Particle Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。塞栓粒子の世界市場レポート2020 / Global Embolization Particle Sales Market Report 2020 / 20QY06-05743資料のイメージです。• レポートコード:20QY06-05743
• 出版社/出版日:QYResearch / 2020年6月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、塞栓粒子のグローバル市場について種類別(ミクロスフェア、粒子(PVA粒子、ゲルフォーム粒子、その他)、薬物溶出ビーズ(DEB)、放射性塞栓ミクロスフェア)、用途別(子宮筋腫塞栓術、前立腺動脈塞栓術(良性前立腺肥大症/BPH治療)、肝腫瘍塞栓術、外傷塞栓術、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・塞栓粒子市場の概要
・世界の主要地域別塞栓粒子市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の塞栓粒子市場規模2015-2026:種類別(ミクロスフェア、粒子(PVA粒子、ゲルフォーム粒子、その他)、薬物溶出ビーズ(DEB)、放射性塞栓ミクロスフェア)
・世界の塞栓粒子市場規模2015-2026:用途別(子宮筋腫塞栓術、前立腺動脈塞栓術(良性前立腺肥大症/BPH治療)、肝腫瘍塞栓術、外傷塞栓術、その他)
・塞栓粒子の北米市場規模2015-2020
・塞栓粒子のヨーロッパ市場規模2015-2020
・塞栓粒子の中国市場規模2015-2020
・塞栓粒子の日本市場規模2015-2020
・塞栓粒子の東南アジア市場規模2015-2020
・塞栓粒子のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Sirtex Medical、Merit Medical、Cook Medical、BTG Medical、Boston Scientific Corporation、Terumo Corporation、HENGRUI Medical、INterface BIOmaterials B.V.、Alicon)
・塞栓粒子の製造コスト分析
・販売チャネル、流通業者、顧客
・塞栓粒子の市場動向・機会・課題
・調査の結論

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
USA has the largest global export quantity and manufacturers in Embolization Particle market, while the Europe is the second sales volume market for Embolization Particle in 2016.

Market Analysis and Insights: Global Embolization Particle Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Embolization Particle market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Embolization Particle industry.
Based on our recent survey, we have several different scenarios about the Embolization Particle YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1523.5 million in 2019. The market size of Embolization Particle will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Embolization Particle Scope and Market Size
The global Embolization Particle market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Embolization Particle market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Embolization Particle market is segmented into
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

Segment by Application, the Embolization Particle market is segmented into
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Other

The Embolization Particle market is analysed and market size information is provided by regions (countries). Segment by Application, the Embolization Particle market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Embolization Particle Market Share Analysis
Embolization Particle market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Embolization Particle business, the date to enter into the Embolization Particle market, Embolization Particle product introduction, recent developments, etc.

The major vendors covered:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon

レポート目次

1 Embolization Particle Market Overview
1.1 Embolization Particle Product Scope
1.2 Embolization Particle Segment by Type
1.2.1 Global Embolization Particle Sales by Type (2020-2026)
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle Segment by Application
1.3.1 Global Embolization Particle Sales Comparison by Application (2020-2026)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Other
1.4 Embolization Particle Market Estimates and Forecasts (2015-2026)
1.4.1 Global Embolization Particle Sales Growth Rate (2015-2026)
1.4.2 Global Embolization Particle Revenue and Growth Rate (2015-2026)
1.4.3 Global Embolization Particle Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Embolization Particle Industry Impact
1.5.1 How the Covid-19 is Affecting the Embolization Particle Industry
1.5.1.1 Embolization Particle Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Embolization Particle Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Embolization Particle Players to Combat Covid-19 Impact

2 Embolization Particle Estimate and Forecast by Region
2.1 Global Embolization Particle Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Embolization Particle Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Embolization Particle Sales Market Share by Region (2015-2020)
2.2.2 Global Embolization Particle Revenue Market Share by Region (2015-2020)
2.3 Global Embolization Particle Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Embolization Particle Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Embolization Particle Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Embolization Particle Estimates and Projections (2015-2026)
2.4.2 Europe Embolization Particle Estimates and Projections (2015-2026)
2.4.3 China Embolization Particle Estimates and Projections (2015-2026)
2.4.4 Japan Embolization Particle Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Embolization Particle Estimates and Projections (2015-2026)
2.4.6 India Embolization Particle Estimates and Projections (2015-2026)
3 Global Embolization Particle Competition Landscape by Players
3.1 Global Top Embolization Particle Players by Sales (2015-2020)
3.2 Global Top Embolization Particle Players by Revenue (2015-2020)
3.3 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Embolization Particle as of 2019)
3.4 Global Embolization Particle Average Price by Company (2015-2020)
3.5 Manufacturers Embolization Particle Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Embolization Particle Players (Opinion Leaders)
4 Global Embolization Particle Market Size by Type
4.1 Global Embolization Particle Historic Market Review by Type (2015-2020)
4.1.1 Global Embolization Particle Sales Market Share by Type (2015-2020)
4.1.2 Global Embolization Particle Revenue Market Share by Type (2015-2020)
4.1.3 Global Embolization Particle Price by Type (2014-2020)
4.2 Global Embolization Particle Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Embolization Particle Sales Forecast by Type (2021-2026)
4.2.2 Global Embolization Particle Revenue Forecast by Type (2021-2026)
4.2.3 Global Embolization Particle Price Forecast by Type (2021-2026)
5 Global Embolization Particle Market Size by Application
5.1 Global Embolization Particle Historic Market Review by Application (2015-2020)
5.1.1 Global Embolization Particle Sales Market Share by Application (2015-2020)
5.1.2 Global Embolization Particle Revenue Market Share by Application (2015-2020)
5.1.3 Global Embolization Particle Price by Application (2015-2020)
5.2 Global Embolization Particle Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Embolization Particle Sales Forecast by Application (2021-2026)
5.2.2 Global Embolization Particle Revenue Forecast by Application (2021-2026)
5.2.3 Global Embolization Particle Price Forecast by Application (2021-2026)

3 North America Embolization Particle Market Facts & Figures
3.2 North America Embolization Particle Sales Market Share by Company (2015-2020)
3.3 North America Embolization Particle Sales Market Share by Type (2015-2020)
3.4 North America Embolization Particle Sales Market Share by Application (2015-2020)

4 Europe Embolization Particle Market Facts & Figures
4.2 Europe Embolization Particle Sales Market Share by Company (2015-2020)
4.3 Europe Embolization Particle Sales Market Share by Type (2015-2020)
4.4 Europe Embolization Particle Sales Market Share by Application (2015-2020)

5 China Embolization Particle Market Facts & Figures
5.2 China Embolization Particle Sales Market Share by Company (2015-2020)
5.3 China Embolization Particle Sales Market Share by Type (2015-2020)
5.4 China Embolization Particle Sales Market Share by Application (2015-2020)

6 Japan Embolization Particle Market Facts & Figures
6.2 Japan Embolization Particle Sales Market Share by Company (2015-2020)
6.3 Japan Embolization Particle Sales Market Share by Type (2015-2020)
6.4 Japan Embolization Particle Sales Market Share by Application (2015-2020)

7 Southeast Asia Embolization Particle Market Facts & Figures
7.2 Southeast Asia Embolization Particle Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Embolization Particle Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Embolization Particle Sales Market Share by Application (2015-2020)

8 India Embolization Particle Market Facts & Figures
8.2 India Embolization Particle Sales Market Share by Company (2015-2020)
8.3 India Embolization Particle Sales Market Share by Type (2015-2020)
8.4 India Embolization Particle Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Embolization Particle Business
12.1 Sirtex Medical
12.1.1 Sirtex Medical Embolization Particle Corporation Information
12.1.2 Sirtex Medical Embolization Particle Business Overview and Total Revenue
12.1.3 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sirtex Medical Embolization Particle Products Offered
12.1.5 Sirtex Medical Recent Development
12.2 Merit Medical
12.2.1 Merit Medical Embolization Particle Corporation Information
12.2.2 Merit Medical Embolization Particle Business Overview and Total Revenue
12.2.3 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merit Medical Embolization Particle Products Offered
12.2.5 Merit Medical Recent Development
12.3 Cook Medical
12.3.1 Cook Medical Embolization Particle Corporation Information
12.3.2 Cook Medical Embolization Particle Business Overview and Total Revenue
12.3.3 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cook Medical Embolization Particle Products Offered
12.3.5 Cook Medical Recent Development
12.4 BTG Medical
12.4.1 BTG Medical Embolization Particle Corporation Information
12.4.2 BTG Medical Embolization Particle Business Overview and Total Revenue
12.4.3 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BTG Medical Embolization Particle Products Offered
12.4.5 BTG Medical Recent Development
12.5 Boston Scientific Corporation
12.5.1 Boston Scientific Corporation Embolization Particle Corporation Information
12.5.2 Boston Scientific Corporation Embolization Particle Business Overview and Total Revenue
12.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Boston Scientific Corporation Embolization Particle Products Offered
12.5.5 Boston Scientific Corporation Recent Development
12.6 Terumo Corporation
12.6.1 Terumo Corporation Embolization Particle Corporation Information
12.6.2 Terumo Corporation Embolization Particle Business Overview and Total Revenue
12.6.3 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Terumo Corporation Embolization Particle Products Offered
12.6.5 Terumo Corporation Recent Development
12.7 HENGRUI Medical
12.7.1 HENGRUI Medical Embolization Particle Corporation Information
12.7.2 HENGRUI Medical Embolization Particle Business Overview and Total Revenue
12.7.3 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2015-2020)
12.7.4 HENGRUI Medical Embolization Particle Products Offered
12.7.5 HENGRUI Medical Recent Development
12.8 INterface BIOmaterials B.V.
12.8.1 INterface BIOmaterials B.V. Embolization Particle Corporation Information
12.8.2 INterface BIOmaterials B.V. Embolization Particle Business Overview and Total Revenue
12.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2015-2020)
12.8.4 INterface BIOmaterials B.V. Embolization Particle Products Offered
12.8.5 INterface BIOmaterials B.V. Recent Development
12.9 Alicon
12.9.1 Alicon Embolization Particle Corporation Information
12.9.2 Alicon Embolization Particle Business Overview and Total Revenue
12.9.3 Alicon Embolization Particle Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Alicon Embolization Particle Products Offered
12.9.5 Alicon Recent Development

13 Embolization Particle Manufacturing Cost Analysis
13.1 Embolization Particle Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Embolization Particle
13.4 Embolization Particle Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Embolization Particle Distributors List
14.3 Embolization Particle Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Embolization Particle Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Embolization Particle Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Embolization Particle Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Embolization Particle Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Embolization Particle Players to Combat Covid-19 Impact
Table 8. Global Market Embolization Particle Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Embolization Particle Sales (K Units) by Region (2015-2020)
Table 10. Global Embolization Particle Sales Market Share by Region (2015-2020)
Table 11. Global Embolization Particle Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Embolization Particle Revenue Share by Region (2015-2020)
Table 13. Global Embolization Particle Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Embolization Particle Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Embolization Particle Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Embolization Particle Revenue Share Forecast by Region (2021-2026)
Table 17. Global Embolization Particle (K Units) of Key Companies (2015-2020)
Table 18. Global Embolization Particle Sales Share by Company (2015-2020)
Table 19. Global Embolization Particle Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Embolization Particle Revenue Share by Company (2015-2020)
Table 21. Global Embolization Particle by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Embolization Particle as of 2019)
Table 22. Global Embolization Particle Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Embolization Particle Manufacturing Sites and Area Served
Table 24. Manufacturers Embolization Particle Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Embolization Particle Players
Table 27. Global Embolization Particle Sales (K Units) by Type (2015-2020)
Table 28. Global Embolization Particle Sales Share by Type (2015-2020)
Table 29. Global Embolization Particle Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Embolization Particle Price (K Units) by Type (2015-2020)
Table 31. Global Embolization Particle Sales Share by Type (2021-2026)
Table 32. Global Embolization Particle Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Embolization Particle Revenue Share by Type (2021-2026)
Table 34. Global Embolization Particle Price (K Units) by Type (2021-2026)
Table 35. Global Embolization Particle Sales (K Units) by Application (2015-2020)
Table 36. Global Embolization Particle Sales Share by Application (2015-2020)
Table 37. Global Embolization Particle Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Embolization Particle Price (K Units) by Application (2015-2020)
Table 39. Global Embolization Particle Sales (K Units) by Application (2021-2026)
Table 40. Global Embolization Particle Sales Share by Application (2021-2026)
Table 41. Global Embolization Particle Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Embolization Particle Revenue Share by Application (2021-2026)
Table 43. Global Embolization Particle Price (K Units) by Application (2021-2026)
Table 44. United States Embolization Particle Sales (K Units) by Company (2015-2020)
Table 45. United States Embolization Particle Sales Market Share by Company (2015-2020)
Table 46. United States Embolization Particle Sales (K Units) by Type (2015-2020)
Table 47. United States Embolization Particle Sales Market Share by Type (2015-2020)
Table 48. United States Embolization Particle Sales (K Units) by Application (2015-2020)
Table 49. United States Embolization Particle Sales Market Share by Application (2015-2020)
Table 50. Europe Embolization Particle Sales (K Units) by Company (2015-2020)
Table 51. Europe Embolization Particle Sales Market Share by Company (2015-2020)
Table 52. Europe Embolization Particle Sales (K Units) by Type (2015-2020)
Table 53. Europe Embolization Particle Sales Market Share by Type (2015-2020)
Table 54. Europe Embolization Particle Sales (K Units) by Application (2015-2020)
Table 55. Europe Embolization Particle Sales Market Share by Type (2015-2020)
Table 56. China Embolization Particle Sales (K Units) by Company (2015-2020)
Table 57. China Embolization Particle Sales Market Share by Company (2015-2020)
Table 58. China Embolization Particle Sales (K Units) by Type (2015-2020)
Table 59. China Embolization Particle Sales Market Share by Type (2015-2020)
Table 60. China Embolization Particle Sales (K Units) by Application (2015-2020)
Table 61. China Embolization Particle Sales Market Share by Application (2015-2020)
Table 62. Japan Embolization Particle Sales (K Units) by Company (2015-2020)
Table 63. Japan Embolization Particle Sales Market Share by Company (2015-2020)
Table 64. Japan Embolization Particle Sales (K Units) by Type (2015-2020)
Table 65. Japan Embolization Particle Sales Market Share by Type (2015-2020)
Table 66. Japan Embolization Particle Sales (K Units) by Application (2015-2020)
Table 67. Japan Embolization Particle Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Embolization Particle Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Embolization Particle Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Embolization Particle Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Embolization Particle Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Embolization Particle Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Embolization Particle Sales Market Share by Application (2015-2020)
Table 74. India Embolization Particle Sales (K Units) by Company (2015-2020)
Table 75. India Embolization Particle Sales Market Share by Company (2015-2020)
Table 76. India Embolization Particle Sales (K Units) by Type (2015-2020)
Table 77. India Embolization Particle Sales Market Share by Type (2015-2020)
Table 78. India Embolization Particle Sales (K Units) by Application (2015-2020)
Table 79. India Embolization Particle Sales Market Share by Application (2015-2020)
Table 80. Sirtex Medical Corporation Information
Table 81. Sirtex Medical Description and Business Overview
Table 82. Sirtex Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sirtex Medical Embolization Particle Product
Table 84. Sirtex Medical Recent Development
Table 85. Merit Medical Corporation Information
Table 86. Merit Medical Description and Business Overview
Table 87. Merit Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Merit Medical Embolization Particle Product
Table 89. Merit Medical Recent Development
Table 90. Cook Medical Corporation Information
Table 91. Cook Medical Description and Business Overview
Table 92. Cook Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Cook Medical Embolization Particle Product
Table 94. Cook Medical Recent Development
Table 95. BTG Medical Corporation Information
Table 96. BTG Medical Description and Business Overview
Table 97. BTG Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. BTG Medical Embolization Particle Product
Table 99. BTG Medical Recent Development
Table 100. Boston Scientific Corporation Corporation Information
Table 101. Boston Scientific Corporation Description and Business Overview
Table 102. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Boston Scientific Corporation Embolization Particle Product
Table 104. Boston Scientific Corporation Recent Development
Table 105. Terumo Corporation Corporation Information
Table 106. Terumo Corporation Description and Business Overview
Table 107. Terumo Corporation Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Terumo Corporation Embolization Particle Product
Table 109. Terumo Corporation Recent Development
Table 110. HENGRUI Medical Corporation Information
Table 111. HENGRUI Medical Description and Business Overview
Table 112. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. HENGRUI Medical Embolization Particle Product
Table 114. HENGRUI Medical Recent Development
Table 115. INterface BIOmaterials B.V. Corporation Information
Table 116. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. INterface BIOmaterials B.V. Description and Business Overview
Table 118. INterface BIOmaterials B.V. Embolization Particle Product
Table 119. INterface BIOmaterials B.V. Recent Development
Table . Alicon Corporation Information
Table . Alicon Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Alicon Description and Business Overview
Table . Alicon Embolization Particle Product
Table . Alicon Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Embolization Particle Distributors List
Table 128. Embolization Particle Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Embolization Particle Product Picture
Figure 2. Global Embolization Particle Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Embolization Particle Market Share by Application in 2020 & 2026
Figure 6. Uterine Fibroid Embolization Examples
Figure 7. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Examples
Figure 8. Liver Tumor Embolization Examples
Figure 9. Trauma Embolization Examples
Figure 10. Other Examples
Figure 11. Global Embolization Particle Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Embolization Particle Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Embolization Particle Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Embolization Particle Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Embolization Particle Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Embolization Particle Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Embolization Particle Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Embolization Particle Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Embolization Particle Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Embolization Particle Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Embolization Particle Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Embolization Particle Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Embolization Particle Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Embolization Particle Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Embolization Particle Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Embolization Particle Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Embolization Particle Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Embolization Particle Players Market Share by Revenue in Embolization Particle 2015 & 2019
Figure 29. Embolization Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Embolization Particle Revenue Share by Type (2015-2020)
Figure 31. Global Embolization Particle Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Embolization Particle Revenue Share by Application (2015-2020)
Figure 33. Global Embolization Particle Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Embolization Particle Sales Market Share by Type in 2019
Figure 35. United States Embolization Particle Sales Market Share by Type in 2019
Figure 36. Europe Embolization Particle Sales Market Share by Company in 2019
Figure 37. Europe Embolization Particle Sales Market Share by Type in 2019
Figure 38. Europe Embolization Particle Sales Market Share by Application in 2019
Figure 39. China Embolization Particle Sales Market Share by Company in 2019
Figure 40. China Embolization Particle Sales Market Share by Type in 2019
Figure 41. China Embolization Particle Sales Market Share by Application in 2019
Figure 42. Japan Embolization Particle Sales Market Share by Company in 2019
Figure 43. Japan Embolization Particle Sales Market Share by Type in 2019
Figure 44. Japan Embolization Particle Sales Market Share by Application in 2019
Figure 45. Southeast Asia Embolization Particle Sales Market Share by Company in 2019
Figure 46. Southeast Asia Embolization Particle Sales Market Share by Type in 2019
Figure 47. Southeast Asia Embolization Particle Sales Market Share by Application in 2019
Figure 48. India Embolization Particle Sales Market Share by Company in 2019
Figure 49. India Embolization Particle Sales Market Share by Type in 2019
Figure 50. India Embolization Particle Sales Market Share by Application in 2019
Figure 51. Sirtex Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merit Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Cook Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. BTG Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Terumo Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. HENGRUI Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. INterface BIOmaterials B.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Alicon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Embolization Particle
Figure 62. Manufacturing Process Analysis of Embolization Particle
Figure 63. Embolization Particle Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed